Nav: Home

Multiple Myeloma Current Events

Multiple Myeloma Current Events, Multiple Myeloma News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 21 | 816 Results
International research group publishes updated criteria for diagnosing multiple myeloma
The International Myeloma Working Group today announced that it has updated the criteria for diagnosing multiple myeloma. (2014-10-26)
Winship multiple myeloma study in The Lancet
Winship multiple myeloma expert Sagar Lonial, M.D., played a key role in the testing of daratumumab (trade name Darzalex), which received accelerated approval from the US FDA in November 2015. (2016-01-06)
New discovery brings hope to treatment of incurable blood cancer
Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. (2010-07-16)
Research team first to identify AF1q protein associated with multiple myeloma, EMD
A group of researchers from the University of Louisville, Japan and Austria is the first to identify a protein, AF1q, associated with multiple myeloma and a condition that occurs in approximately one-fourth of very aggressive multiple myeloma, extramedullary disease or EMD. (2016-06-10)
Mayo Clinic study defines patients at greater risk for developing multiple myeloma and related bone marrow cancers
A Mayo Clinic study, published in the current edition of New England Journal of Medicine, has defined for the first time within a large population the rate at which patients with a monoclonal protein (M-protein) in their blood develop multiple myeloma, a fatal cancer of the bone marrow. (2002-02-22)
Mayo Clinic study shows that choice of medical center impacts life expectancy of multiple myeloma patients
People diagnosed with multiple myeloma are more likely to live longer if they are treated at a medical center that sees many patients with this blood cancer. (2016-10-26)
Thalidomide should be added to treatment combination for multiple myeloma
Adding thalidomide to the standard combination of drugs used to treat multiple myeloma in elderly patients could improve event-free survival, according to a randomised trial in this week's issue of The Lancet. (2006-03-09)
Weight loss may help prevent multiple myeloma
Carrying extra weight increases a person's risk that a benign blood disorder will develop into multiple myeloma, a blood cancer. (2016-11-18)
Study identifies key molecules in multiple myeloma
New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma. (2010-10-26)
One-size treatment for blood cancer probably doesn't fit all, USC researchers say
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent. (2017-11-22)
New discovery may lead to therapy for incurable blood cancer
A recent finding may lead to new treatments for multiple myeloma, an incurable cancer of immune cells called plasma cells that are present in the blood and bone marrow. (2004-02-23)
Northwestern Memorial enrolling participants in two trials on new drug to fight deadly cancer
Northwestern Memorial Hospital (NMH) is participating in two research studies on Revimid, a new drug, being developed by Celgene Corporation, for people with multiple myeloma. (2003-12-02)
NCI awards SPORE grant to multiple myeloma research team from Mayo Clinic Cancer Center
A team of Mayo Clinic Cancer Center scientists has been awarded a Specialized Program of Research Excellence (SPORE) grant in multiple myeloma from the National Cancer Institute. (2015-08-31)
Scientists stalk PPAR-gamma, find novel cancer connection
In laboratory tests on multiple myeloma cells, researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. (2004-12-08)
Study lays groundwork for blood test to aid in the detection and monitoring of myeloma
Only 5 percent of myeloma cases are stage I when diagnosed. (2015-09-30)
Rates of kidney failure due to blood cancer are declining
The incidence of kidney failure from multiple myeloma decreased by about 20 percent from 2001-2002 to 2009-2010. (2015-10-29)
New study suggests possible genetic links between environmental toxins and multiple myeloma
Several SNPs associated with bone disease in myeloma have been identified and reported in a paper in the current issue of Leukemia. (2009-08-13)
How to attack and paralyze myeloma cells
Professor Martin Bornhäuser and Dr. Christoph Röllig, both experts in the field of blood cancer at the Carl Gustav Carus Medical Faculty of the TU Dresden, have now turned their long-term clinical and research experience in treatment of multiple myeloma into an instructive review for other physicians. (2015-01-20)
Oral drug sets a new survival standard for bone marrow cancer
Findings from two large, international clinical trials show (2007-11-21)
Study shows benefit of new maintenance therapy for multiple myeloma
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. (2012-05-11)
The IMF says journal editorial documents dramatic increase in survival since the 1980s
The International Myeloma Foundation today said survival outcomes have improved dramatically for patients with multiple myeloma, cancer in the bone marrow that affects blood cell production. (2008-09-11)
Drug combination highly effective for newly diagnosed myeloma patients
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses- the best reported to date. (2012-06-04)
TGen professor discusses benefits of whole genome sequencing in study of multiple myeloma
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute (TGen) will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center. (2013-04-02)
Thalidomide therapy for multiple myeloma patients may lengthen survival, researchers report
Nearly one-third of patients with advanced multiple myeloma who had failed current standard therapy of chemotherapy or stem cell transplantation responded to thalidomide for a median duration of nearly one year in a Mayo Clinic study of the effects of thalidomide on myeloma. (2003-01-14)
Inhibition of EZH2 might be new therapy of multiple myeloma
In a study published in the scientific journal Oncotarget, researchers from Uppsala University show how the protein EZH2 affects the development of multiple myeloma, and that inhibition of EZH2 could be used as a new strategy to treat the disease. (2017-01-12)
Possible treatment for serious blood cancer
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. (2013-05-06)
As body mass index increases, so does spread of multiple myeloma
In a new study, American University researchers show how, as body mass index increases, so does the growth and spread of the blood cancer multiple myeloma. (2016-07-12)
CWRU research examines over-the-counter drug's effect on chemo's side effects
Beth Faiman M.S.N., C.N.P., a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects for people with blood and bone marrow cancers. (2011-09-19)
Treatment with anti-anemia drugs may not be safe for multiple myeloma patients
A recent study published in American Journal of Hematology demonstrated that Erythropoiesis-stimulating agents, a widely used drug to treat anemia, may have a negative impact on the survival of myeloma patients. (2008-08-04)
Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science University Knight Cancer Institute. (2012-05-15)
Mayo Clinic study shows thalidomide may delay progression of early stage multiple myeloma
A Mayo Clinic study is the first to show that for some patients with early stage multiple myeloma, the drug thalidomide may effectively delay the need for chemotherapy or more aggressive treatment for as much as two years. (2003-04-01)
Scientists find evidence of how incurable cancer develops
Researchers have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. (2015-10-16)
Novel drug for multiple myeloma continues to show promise in early study
A first-in-class investigational drug for relapsed and refractory multiple myeloma, an incurable cancer of the bone marrow, continues to show promising results in a study of myeloma patients who have failed numerous other treatments, Dana-Farber Cancer Institute scientists will report at the annual meeting of the American Society of Hematology in Philadelphia on Monday, Dec. (2002-12-09)
Sylvester researchers develop novel disease model to study multiple myeloma
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an animal model that allows them to better understand the mechanisms that lead to the development of multiple myeloma, a hematologic cancer of plasma cells, and the amyloidosis that sometimes accompanies it. (2016-05-05)
Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds
Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have found in a study presented at the annual meeting of the American Society of Hematology. (2014-12-07)
New therapeutic options for newly diagnosed multiple myeloma patients
Mayo Clinic researchers today presented results of a phase II trial of myeloma induction therapy -- a first step therapy designed to reduce cancer cells numbers -- with cyclophosphamide, bortezomib, and dexamethasone (Cybor-D) showing an improved response over the traditional lenalidomide-dexamethasone (L-Dex) therapy. (2007-12-10)
NICE approves use of lenalidomide in patients with multiple myeloma who have received 2 or more previous therapies
Around 2,000 multiple myeloma sufferers in the UK could have their lives extended by around three months after a decision by the UK National Institute for Health and Clinical Excellence to approve lenalidomide in those patients who have received two or more previous therapies -- provided that the cost of cycles beyond the 26th cycle of treatment are met by the drug manufacturer. (2009-06-17)
Human C-reactive protein regulates myeloma tumor cell growth and survival
Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. (2007-09-10)
TJP1 protein may identify multiple myeloma patients most likely to benefit from proteasome inhibitors
A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity, according to a study led by the University of Texas MD Anderson Cancer Center. (2016-04-28)
New drug class gives hope for better treatments for incurable myeloma
Australian researchers have discovered that a new class of anti-cancer agents may be effective in treating multiple myeloma, an incurable bone marrow cancer. (2016-08-08)
Page 1 of 21 | 816 Results
   First   Previous   Next      Last   

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Big Five
What are the five biggest global challenges we face right now — and what can we do about them? This hour, TED speakers explore some radical solutions to these enduring problems. Guests include geoengineer Tim Kruger, president of the International Rescue Committee David Miliband, political scientist Ian Bremmer, global data analyst Sarah Menker, and historian Rutger Bregman.
Now Playing: Science for the People

#456 Inside a Conservation NGO
This week we take a close look at conservation NGOS: what they do, how they work, and - most importantly - why we need them. We'll be speaking with Shyla Raghav, the Climate Change Lead at Conservation International, about using strategy and policy to tackle climate change. Then we'll speak with Rebecca Shaw, Lead Scientist at the World Wildlife Fund, about how and why you should get involved with conservation initiatives.